{"transactions":[{"id":4630962,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-10-05T21:40:14.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1882,"price":130.79,"value":246146.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing."}],"balance_after":17357,"source":{"system":"sec-edgar","filing":"0001145197-26-000186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924996/000114519726000186/form4.xml","form_type":"4"}},{"id":880103,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-26T21:05:28.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":9946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Non-Qualified Stock Option (\"Option\") Award.  The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":9946,"derivative":{"exercise_price":245.25,"expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":9946},"source":{"system":"sec-edgar","filing":"0001145197-26-000059","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000059/form4.xml","form_type":"4"}},{"id":880102,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-26T21:05:28.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":3822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual Restricted Stock Unit (\"RSU\") award. RSUs vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis."}],"balance_after":19159,"source":{"system":"sec-edgar","filing":"0001145197-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000059/form4.xml","form_type":"4"}},{"id":1027819,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-02T20:19:14.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":1641,"price":305.98,"value":502113.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":1641,"derivative":{"exercise_price":305.98,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":1641},"source":{"system":"sec-edgar","filing":"0001145197-25-000055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000055/form4.xml","form_type":"4"}},{"id":1027818,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2025-10-02T20:19:14.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":11708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit (\"RSU\") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis."}],"balance_after":15337,"source":{"system":"sec-edgar","filing":"0001145197-25-000055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519725000055/form4.xml","form_type":"4"}},{"id":1125781,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-06-03T21:05:12.000Z","date":"2025-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":185,"price":135.63,"value":25091.55,"ownership":{"direct":true},"balance_after":17297,"source":{"system":"sec-edgar","filing":"0001127602-25-016569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016569/form4.xml","form_type":"4"}},{"id":1125780,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-06-03T21:05:12.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7152,"price":135.63,"value":970025.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029."}],"balance_after":17482,"source":{"system":"sec-edgar","filing":"0001127602-25-016569","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225016569/form4.xml","form_type":"4"}},{"id":1130914,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-05-29T21:10:59.000Z","date":"2025-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":141,"price":136.73,"value":19278.93,"ownership":{"direct":true},"balance_after":10330,"source":{"system":"sec-edgar","filing":"0001127602-25-015906","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015906/form4.xml","form_type":"4"}},{"id":1130913,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-05-29T21:10:59.000Z","date":"2025-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":190,"price":136.73,"value":25978.7,"ownership":{"direct":true},"balance_after":10471,"source":{"system":"sec-edgar","filing":"0001127602-25-015906","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015906/form4.xml","form_type":"4"}},{"id":1133793,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-27T20:09:45.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2026. The Reporting Person has elected to defer settlement of these RSUs pursuant to the Insulet Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the termination of the Reporting Person's service as a Director."}],"balance_after":3629,"source":{"system":"sec-edgar","filing":"0001127602-25-015656","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760225015656/form4.xml","form_type":"4"}},{"id":1159721,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-05-05T21:44:33.000Z","date":"2025-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":889,"price":116.89,"value":103915.21,"ownership":{"direct":true},"balance_after":10661,"source":{"system":"sec-edgar","filing":"0001127602-25-013391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225013391/form4.xml","form_type":"4"}},{"id":1287755,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-02-03T22:17:07.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":165.57,"value":151330.98,"ownership":{"direct":true},"balance_after":11550,"source":{"system":"sec-edgar","filing":"0001127602-25-002799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002799/form4.xml","form_type":"4"}},{"id":1287754,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2025-02-03T22:17:07.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":2704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022."}],"balance_after":12464,"source":{"system":"sec-edgar","filing":"0001127602-25-002799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225002799/form4.xml","form_type":"4"}},{"id":1493132,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:17:30.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4906,"price":208.44,"value":1022606.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock options vest as follows: 1,226 on May 31, 2025,  1,227 on May 31, 2026,  1,226 on May 31, 2027, and  1,227 on May 31, 2028."}],"balance_after":4906,"derivative":{"exercise_price":208.44,"exercise_date":"2025-05-31","expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":4906},"source":{"system":"sec-edgar","filing":"0001127602-24-017663","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017663/form4.xml","form_type":"4"}},{"id":1493131,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-06-04T20:17:30.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 539 on May 31, 2025,  540 on May 31, 2026,  540 on May 31, 2027, and  540 on May 31, 2028."}],"balance_after":9760,"source":{"system":"sec-edgar","filing":"0001127602-24-017663","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017663/form4.xml","form_type":"4"}},{"id":1498272,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-05-30T23:56:15.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":194,"price":217.21,"value":42138.74,"ownership":{"direct":true},"balance_after":7601,"source":{"system":"sec-edgar","filing":"0001127602-24-017055","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017055/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-29"}},{"id":1498271,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-05-30T23:56:15.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":212,"price":217.21,"value":46048.52,"ownership":{"direct":true},"balance_after":7795,"source":{"system":"sec-edgar","filing":"0001127602-24-017055","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017055/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-29"}},{"id":1499433,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:58.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":144,"price":217.21,"value":31278.24,"ownership":{"direct":true},"balance_after":7651,"source":{"system":"sec-edgar","filing":"0001127602-24-016811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016811/form4.xml","form_type":"4"}},{"id":1499432,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-05-29T21:38:58.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":212,"price":217.21,"value":46048.52,"ownership":{"direct":true},"balance_after":7795,"source":{"system":"sec-edgar","filing":"0001127602-24-016811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016811/form4.xml","form_type":"4"}},{"id":1504016,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T21:12:20.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2025.  The Reporting Person has elected to defer settlement of these RSUs pursuant to the Insulet Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the termination of the Reporting Person's service as a Director."}],"balance_after":2851,"source":{"system":"sec-edgar","filing":"0001127602-24-016462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224016462/form4.xml","form_type":"4"}},{"id":1528884,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2024-05-03T21:03:23.000Z","date":"2024-05-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":893,"price":232.69,"value":207792.17,"ownership":{"direct":true},"balance_after":8007,"source":{"system":"sec-edgar","filing":"0001127602-24-014153","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224014153/form4.xml","form_type":"4"}},{"id":1674394,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-22T21:10:59.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":1471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Initial equity award in the form of restricted stock units (\"RSUs\").  RSUs vest 50% on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant.  The RSUs are settled in shares of common stock on a one-for-one basis."}],"balance_after":1471,"source":{"system":"sec-edgar","filing":"0001127602-24-001807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760224001807/form4.xml","form_type":"4"}},{"id":1873627,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-31T18:39:46.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":5314,"price":194.12,"value":1031553.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,328 on May 26, 2024, 1,329 on May 26, 2025, 1,328 on May 26, 2026 and 1,329 on May 26, 2027."}],"balance_after":5314,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":5314},"source":{"system":"sec-edgar","filing":"0001127602-23-017170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017170/form4.xml","form_type":"4"}},{"id":1873626,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-05-31T18:39:46.000Z","date":"2023-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":137,"price":194.12,"value":26594.44,"ownership":{"direct":true},"balance_after":8900,"source":{"system":"sec-edgar","filing":"0001127602-23-017170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017170/form4.xml","form_type":"4"}},{"id":1873625,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2023-05-31T18:39:46.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":2215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units vest as follows: 553 on May 26, 2024, 554 on May 26, 2025, 554 on May 26, 2026 and 554 on May 26, 2027."}],"balance_after":9037,"source":{"system":"sec-edgar","filing":"0001127602-23-017170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017170/form4.xml","form_type":"4"}},{"id":2249844,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-01T21:15:49.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":4423,"price":244.41,"value":1081025.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,105 on May 27, 2023, 1,106 on May 27, 2024, 1,106 on May 27, 2025 and 1,106 on May 27, 2026."}],"balance_after":4423,"derivative":{"exercise_price":244.41,"exercise_date":"2023-05-27","expiration_date":"2032-05-27","underlying":"Common Stock","underlying_shares":4423},"source":{"system":"sec-edgar","filing":"0001127602-22-016211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016211/form4.xml","form_type":"4"}},{"id":2249843,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CFO"}}],"security":"Common Stock","published_at":"2022-06-01T21:15:49.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":1637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 409 on May 27, 2023, 409 on May 27, 2024, 409 on May 27, 2025 and 410 on May 27, 2026."}],"balance_after":6822,"source":{"system":"sec-edgar","filing":"0001127602-22-016211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016211/form4.xml","form_type":"4"}},{"id":2282664,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-05-04T20:38:56.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":4649,"price":245.88,"value":1143096.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 2,324 on May 02, 2024, and 2,325 on May 02, 2025."}],"balance_after":4649,"derivative":{"exercise_price":245.88,"exercise_date":"2024-05-02","expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":4649},"source":{"system":"sec-edgar","filing":"0001127602-22-013202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222013202/form4.xml","form_type":"4"}},{"id":2282663,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":64536,"kind":"person","name":"Pease Flavia","position":1,"cik":"0001924996","reported_name":"Pease Flavia","relationship":{"officer":true,"officer_title":"Corporate Executive VP"}}],"security":"Common Stock","published_at":"2022-05-04T20:38:56.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":5185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 2,592 on May 02, 2024, and 2,593 on May 02, 2025."}],"balance_after":5185,"source":{"system":"sec-edgar","filing":"0001127602-22-013202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222013202/form4.xml","form_type":"4"}}]}